Betalutin Trial for Non-Hodgkin’s Lymphoma Patients Opens New Expansion Cohort
News
The LYMRIT 37-01 Phase 1/2 trial assessing Betalutin in non-Hodgkin’s lymphoma patients will continue to evaluate Betalutin administered after pre-dosing with lilotomab in a Phase 2 expansion cohort of Arm 4. The ... Read more